©The Author(s) 2025.
World J Gastrointest Oncol. Dec 15, 2025; 17(12): 114037
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.114037
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.114037
Table 3 Clinical model construction
| Dataset | Model name | Accuracy | AUC | 95%CI | Sensitivity | Specificity |
| Training | RandomForest | 0.677 | 0.766 | 0.6884-0.8443 | 0.893 | 0.519 |
| Test | RandomForest | 0.517 | 0.650 | 0.5106-0.7900 | 0.870 | 0.286 |
| Training | ExtraTrees | 0.632 | 0.678 | 0.5881-0.7671 | 0.661 | 0.61 |
| Test | ExtraTrees | 0.534 | 0.598 | 0.4506-0.7457 | 0.696 | 0.429 |
| Training | MLP | 0.579 | 0.634 | 0.5398-0.7281 | 0.839 | 0.39 |
| Test | MLP | 0.466 | 0.504 | 0.3482-0.6605 | 0.913 | 0.171 |
- Citation: Huang LH, Fang YJ, Zheng XJ, Huang C, Li CL, Yu B, Huang MJ, Qin SJ, Huang DY, Lu DW. Application of multimodal fusion technology in early recurrence prediction and pathological analysis of hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(12): 114037
- URL: https://www.wjgnet.com/1948-5204/full/v17/i12/114037.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i12.114037